Fibromyalgia syndrome: approach to management.
The management of fibromyalgia syndrome (FMS) has traditionally been multimodal and multidisciplinary, including education, physical modalities, and medication. In this article, an acronym is offered to help the clinician remember the important components of management. An improved understanding of the pathogenesis of FMS has allowed substantial refinements in its treatment. This is particularly true for medications that target specific symptom domains, allowing individualization of therapy. Since all FMS patients experience pain, there has been emphasis on that domain although medications are now available to address two or more domains with monotherapy. In addition, a logical basis is provided to help the clinician design strategic polypharmacy..
Russell
I Jon
IJ
University Clinical Research Center, University of Texas Health Science Center, San Antonio, TX 78229-3900, USA. russell@uthscsa.dcci.com
D000700:Analgesics / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D005356:Fibromyalgia / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D010348:Patient Care Team; D010353:Patient Education as Topic; D026741:Physical Therapy Modalities; D011619:Psychotropic Drugs / Q000627:therapeutic use
D000700:Analgesics; D011619:Psychotropic Drugs